...end. NT-501 consists of encapsulated human cells genetically modified to secrete ciliary neurotrophic factor (CNTF). Neurotech Pharmaceuticals...
...BCVA) and reading speed Status: Phase II data Milestone: Start Phase III (year end 2017) Julian Zhu NT-501 Renexus Neurotech Pharmaceuticals...

...cytokines Phase II Neuraltus Pharmaceuticals Inc. NP001 Small molecule regulator of macrophage activation Phase II Global Neurotech (GNT) Pharma Co. Ltd....

...has LY3023703 , a PTGES inhibitor, in Phase II testing to treat osteoarthritis and pain. Global Neurotech (GNT) Pharma Co. Ltd....

...transfect multiple cell types across a broad region of the retina cannot be turned off. Neurotech Pharmaceuticals...
...Co. Ltd. (Tokyo:4523), Tokyo, Japan Eyevensys S.A.S., Paris, France Genentech Inc., South San Francisco, Calif. Neurotech Pharmaceuticals...
...the eyes Company Compound Therapeutic modality Delivery route Proposed dosing schedule Description Lead indication Status Neurotech Pharmaceuticals...

...who have been treated with >=3 anti-VEGF injections and have demonstrated a good clinical response. Neurotech Pharmaceuticals...

...Park, N.C.) hired Rhett Schiffman as CMO and SVP of development. Schiffman was CMO at Neurotech Pharmaceuticals...

...of NuPathe Inc. , which was acquired by Teva Pharmaceutical Industries Ltd. (NYSE:TEVA). Ophthalmic play Neurotech Pharmaceuticals...

...with preclinical programs designed to target neuroinflammation associated with ALS include FPRT Bio Inc. ; Global Neurotech (GNT) Pharma Co. Ltd....
...enter the clinic in 2015. Companies and Institutions Mentioned FPRT Bio Inc. , Scranton, Pa. Global Neurotech (GNT) Pharma Co. Ltd....

...JNK will act at different stages of an ischemic insult," said Zocere CEO Wayne Laslie. Global Neurotech (GNT) Pharma Co. Ltd....
...Institutions Mentioned Boehringer Ingelheim GmbH , Ingelheim, Germany Genentech Inc. , South San Francisco, Calif. Global Neurotech (GNT) Pharma Co. Ltd....

...C5b-9 membrane attack complex (MAC) in preclinical development for ALS, MS and myasthenia gravis. Additionally, Global Neurotech (GNT) Pharma Co. Ltd....
...Phase II in both indications. Companies and Institutions Mentioned FPRT Bio Inc. , Scranton, Pa. Global Neurotech (GNT) Pharma Co. Ltd....